Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract

被引:7
作者
Compare, Debora [1 ]
Nardone, Olga [1 ]
Nardone, Gerardo [1 ]
机构
[1] Univ Naples Federico II, Dept Clin & Expt Med, Gastroenterol Unit, Via S Pansini 5, I-80131 Naples, Italy
来源
PHARMACEUTICALS | 2010年 / 3卷 / 08期
关键词
cyclooxygenase-2; non-steroidal anti-inflammatory drugs; esophageal cancer; gastric cancer; colorectal cancer;
D O I
10.3390/ph3082495
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
It is estimated that underlying infections and inflammatory responses are linked to 15-20% of all deaths from cancer worldwide. Inflammation is a physiologic process in response to tissue damage resulting from microbial pathogen infection, chemical irritation, and/or wounding. Tissues injured throughout the recruitment of inflammatory cells such as macrophages and neutrophils, generate a great amount of growth factors, cytokines, and reactive oxygen and nitrogen species that may cause DNA damage that in turn predisposes to the transformation from chronic inflammation to neoplasia. Cyclooxygenase (COX), playing a key role in cell homeostasis, angiogenesis and tumourigenesis, may represent the link between inflammation and cancer. Currently COX is becoming a pharmacological target for cancer prevention and treatment.
引用
收藏
页码:2495 / 2516
页数:22
相关论文
共 145 条
[1]   Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis [J].
Abnet, C. C. ;
Freedman, N. D. ;
Kamangar, F. ;
Leitzmann, M. F. ;
Hollenbeck, A. R. ;
Schatzkin, A. .
BRITISH JOURNAL OF CANCER, 2009, 100 (03) :551-557
[2]   GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[3]   The role of cytokines and chemokines on tumor progression: A review [J].
Ardestani, SK ;
Inserra, P ;
Solkoff, D ;
Watson, RR .
CANCER DETECTION AND PREVENTION, 1999, 23 (03) :215-225
[4]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[5]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
[6]   A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas [J].
Baron, John A. ;
Sandler, Robert S. ;
Bresalier, Robert S. ;
Quan, Hui ;
Riddell, Robert ;
Lanas, Angel ;
Bolognese, James A. ;
Oxenius, Bettina ;
Horgan, Kevin ;
Loftus, Susan ;
Morton, Dion G. .
GASTROENTEROLOGY, 2006, 131 (06) :1674-1682
[7]   Increased toxicity and lack of efficacy of rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study [J].
Becerra, CR ;
Frenkel, EP ;
Asrfaq, R ;
Gaynor, RB .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (06) :868-872
[8]   Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial [J].
Bertagnolli, Monica M. ;
Eagle, Craig J. ;
Zauber, Ann G. ;
Redston, Mark ;
Breazna, Aurora ;
Kim, KyungMann ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Umar, Asad ;
Bagheri, Donya ;
Collins, Neal T. ;
Burn, John ;
Chung, Daniel C. ;
Dewar, Thomas ;
Foley, T. Raymond ;
Hoffman, Neville ;
Macrae, Finlay ;
Pruitt, Ronald E. ;
Saltzman, John R. ;
Salzberg, Bruce ;
Sylwestrowicz, Thomas ;
Hawk, Ernest T. .
CANCER PREVENTION RESEARCH, 2009, 2 (04) :310-321
[9]   INTESTINAL TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
BJARNASON, I ;
MACPHERSON, AJS .
PHARMACOLOGY & THERAPEUTICS, 1994, 62 (1-2) :145-157
[10]  
Boolbol SK, 1996, CANCER RES, V56, P2556